Literature DB >> 6330564

Generation of beta-globin by sequence-specific proteolysis of a hybrid protein produced in Escherichia coli.

K Nagai, H C Thøgersen.   

Abstract

High-level expression of many eukaryotic genes has proved difficult to achieve even when a strong promoter and the ribosome binding sequence from highly expressed Escherichia coli genes have been placed in front of the coding sequences. To overcome this problem, many eukaryotic proteins have been efficiently produced as hybrids after fusion of their genes with a coding sequence of E. coli genes. However, such hybrid proteins are not suitable for functional studies or clinical use unless the authentic protein sequence can be released by specific cleavage. Here, we have inserted the sequence Ile-Glu-Gly-Arg between the 31 amino-terminal residues of lambda cII protein and Val 1 of human beta-globin, and produced this hybrid in high yield in E. coli. We then cleaved the hybrid specifically at the single arginine, using blood coagulation factor Xa and thus liberated the authentic beta-globin chain. As factor Xa is specific for the tetrapeptide Ile-Glu-Gly-Arg, which is rare in protein sequences, our expression/cleavage system is applicable to the efficient production of many eukaryotic proteins.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330564     DOI: 10.1038/309810a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  66 in total

1.  Utilization of Escherichia coli outer-membrane endoprotease OmpT variants as processing enzymes for production of peptides from designer fusion proteins.

Authors:  Kazuaki Okuno; Masayuki Yabuta; Toshihiko Ooi; Shinichi Kinoshita
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

2.  Steric and hydrophobic determinants of the solubilities of recombinant sickle cell hemoglobins.

Authors:  M T Bihoreau; V Baudin; M Marden; N Lacaze; B Bohn; J Kister; O Schaad; A Dumoulin; S J Edelstein; C Poyart
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

3.  Extracellular production system of heterologous peptide driven by a secretory protease inhibitor of Streptomyces.

Authors:  S Taguchi; M Maeno; H Momose
Journal:  Appl Microbiol Biotechnol       Date:  1992-03       Impact factor: 4.813

4.  Addition of missing loops and domains to protein models by x-ray solution scattering.

Authors:  Maxim V Petoukhov; Nigel A J Eady; Katherine A Brown; Dmitri I Svergun
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

5.  The mitochondrial message-specific mRNA protectors Cbp1 and Pet309 are associated in a high-molecular weight complex.

Authors:  Kirsten Krause; Renata Lopes de Souza; Douglas G W Roberts; Carol L Dieckmann
Journal:  Mol Biol Cell       Date:  2004-03-26       Impact factor: 4.138

6.  A novel protein (suef) programmed by the leftwards strand of a chimeric cDNA stops the expression of several proteins in E. coli.

Authors:  E Preddie; J E Bergmann
Journal:  Nucleic Acids Res       Date:  1990-11-11       Impact factor: 16.971

7.  Carbohydrate-recognition domains as tools for rapid purification of recombinant eukaryotic proteins.

Authors:  M E Taylor; K Drickamer
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

8.  Hyperexpression and purification of Escherichia coli adenylate cyclase using a vector designed for expression of lethal gene products.

Authors:  P Reddy; A Peterkofsky; K McKenney
Journal:  Nucleic Acids Res       Date:  1989-12-25       Impact factor: 16.971

9.  Proliferative T-cell response to glycoprotein B of the human herpes viruses: the influence of MHC and sequence of infection on the pattern of cross-reactivity.

Authors:  W L Chan; M L Tizard; L Faulkner
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

10.  Cloning, expression in Escherichia coli, and reconstitution of human myoglobin.

Authors:  R Varadarajan; A Szabo; S G Boxer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.